lobbying_activities: 745033

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
745033	6312a200-1e5a-4c5d-805f-eb8115463119	Q1	MEHLMAN CONSULTING, INC.	284950	FOREST LABORATORIES INC	2009	first_quarter	MMM	Health reform and related health care issues, including potential changes to Medicaid rebate. S.525, The Pharmaceutical Market Access and Drug Safety Act of 2009.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2009-04-06T15:58:15-04:00